Apoprotein composition of very low density lipoproteins of human serum - PubMed (original) (raw)
Apoprotein composition of very low density lipoproteins of human serum
J P Kane et al. J Clin Invest. 1975 Dec.
Abstract
Methods for quantitation of the major apoproteins of human serum very low density lipoprotein have been developed employing tetramethylurea, which delipidates the lipoprotein and selectively precipitates apolipoprotein B. Six soluble apoproteins are separated by electrophoresis in polyacrylamide gel. One of these is a previously unrecognized species of R-alanine (R4-alanine), more anionic than the R3-alanine polypeptide. Conditions of staining have been found which yield reproducibly linear chromogenic response with native lipoprotein and with each purified apoprotein. Recovery of protein in the seven species measured accounts for over 97% of the total in the very low density lipoprotein of normolipidemic individuals and in most samples from individuals with endogenous hyperlipemia. The mean content of apolipoprotein B in 43 samples from normolipidemic subjects was 36.9(+/-1.2 SEM)% of total protein, The distribution of the major soluble apoproteins as mean (+/-SEM) percentage of the soluble fraction was : R-serine, 5.3+/-o.5; arginine-rich, 20.6+/-1.0; R-glutamic, 10.6+/-0.4; R2-alanine, 28.3+/-0.7; R3-alanine, 26.9+/-0.5; and R4-alanine, 8.0+/-0.5. Distribution of the apoproteins was a function of particle diameter of very low density lipoprotein in fractions separated by gel permeation chromatography and by density gradient ultracentrifugation. In fractions below 700-800 A, apolipoprotein B comprised an increasing percentage of the total protein with decreasing particle diameter. Among the soluble proteins the percentage of the arginine-rich and R-serine polypeptides increased and that of the R-glutamic polypeptide declined progressively with decreasing particle size. Apoprotein distribution was similar in fractions of similar particle size from normolipidemic and hyperlipemic subjects with the exception that all fractions from the hyperlipemic subjects contained more R-serine and some, more arginine rich polypeptide. Even in the absence of chylomicrons, the distribution of soluble apoproteins in particles of diameters greater than 700-800 A was usually similar to that of the smallest particles. This suggests that the largest particles may include products of the partial catabolism of chylomicrons.
Similar articles
- The distribution and partial characterization of the serum apolipoproteins in the guinea pig.
Chapman MJ, Mills GL, Ledford JH. Chapman MJ, et al. Biochem J. 1975 Aug;149(2):423-36. doi: 10.1042/bj1490423. Biochem J. 1975. PMID: 170915 Free PMC article. - [Change in the apoproteins of very low density lipoproteins in the blood in hypertriglyceridemia].
Perova NV, Gerasimova EN, Chernysheva NP, Nikitina NA, Shcherbakova IA. Perova NV, et al. Vopr Med Khim. 1979 Mar-Apr;25(2):185-92. Vopr Med Khim. 1979. PMID: 220803 Russian. - The interaction of heparin with an apoprotein of human very low density lipoprotein.
Shelburne FA, Quarfordt SH. Shelburne FA, et al. J Clin Invest. 1977 Oct;60(4):944-50. doi: 10.1172/JCI108849. J Clin Invest. 1977. PMID: 197127 Free PMC article. - Limited tryptic digestion of human serum low-density lipoprotein: isolation and characterisation of the protein-deficient particle and of its apoprotein.
Chapman MJ, Goldstein S, Mills GL. Chapman MJ, et al. Eur J Biochem. 1978 Jul 3;87(3):475-88. doi: 10.1111/j.1432-1033.1978.tb12398.x. Eur J Biochem. 1978. PMID: 210015 Review. - Determination of partial specific volumes for lipid-associated proteins.
Steele JC Jr, Tanford C, Reynolds JA. Steele JC Jr, et al. Methods Enzymol. 1978;48:11-23. doi: 10.1016/s0076-6879(78)48004-8. Methods Enzymol. 1978. PMID: 345043 Review. No abstract available.
Cited by
- Novel protein-truncating variant in the APOB gene may protect from coronary artery disease and adverse cardiovascular events.
Mango G, Osti N, Udali S, Vareschi A, Malerba G, Giorgetti A, Pizzolo F, Friso S, Girelli D, Olivieri O, Castagna A, Martinelli N. Mango G, et al. Atheroscler Plus. 2022 Jun 23;49:42-46. doi: 10.1016/j.athplu.2022.06.001. eCollection 2022 Aug. Atheroscler Plus. 2022. PMID: 36644201 Free PMC article. - Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins.
Bas S, James RW, Gabay C. Bas S, et al. BMC Immunol. 2010 Sep 16;11:46. doi: 10.1186/1471-2172-11-46. BMC Immunol. 2010. PMID: 20846396 Free PMC article. - Regulation of lipoprotein metabolism by estrogen in inbred strains of mice occurs primarily by posttranscriptional mechanisms.
Srivastava RA, Krul ES, Lin RC, Schonfeld G. Srivastava RA, et al. Mol Cell Biochem. 1997 Aug;173(1-2):161-8. doi: 10.1023/a:1006896131186. Mol Cell Biochem. 1997. PMID: 9278267 - Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.
Karpe F, Steiner G, Olivecrona T, Carlson LA, Hamsten A. Karpe F, et al. J Clin Invest. 1993 Mar;91(3):748-58. doi: 10.1172/JCI116293. J Clin Invest. 1993. PMID: 8450056 Free PMC article. - Comparison of immunoturbidimetric and Lowry methods for measuring concentration of very low density lipoprotein apolipoprotein B-100 in plasma.
Cummings MH, Watts GF, Lumb PJ, Slavin BM. Cummings MH, et al. J Clin Pathol. 1994 Feb;47(2):176-8. doi: 10.1136/jcp.47.2.176. J Clin Pathol. 1994. PMID: 8132836 Free PMC article.
References
- Bull Soc Chim Biol (Paris). 1961;43:811-6 - PubMed
- Arch Biochem Biophys. 1962 Aug;98:271-3 - PubMed
- J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
- J Clin Invest. 1975 Sep;56(3):603-15 - PubMed
- Anal Biochem. 1971 Nov;44(1):81-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources